Mereo BioPharma Group PLC (MREO)
3.09
-0.17
(-5.21%)
USD |
NASDAQ |
May 06, 16:00
3.105
+0.02
(+0.49%)
After-Hours: 20:00
Mereo BioPharma Group Total Liabilities (Quarterly): 15.96M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.96M |
| June 30, 2023 | 28.88M |
| June 30, 2023 | 28.88M |
| December 31, 2022 | 26.01M |
| June 30, 2022 | 46.64M |
| June 30, 2022 | 46.64M |
| December 31, 2021 | 51.85M |
| June 30, 2021 | 88.90M |
| June 30, 2021 | 88.90M |
| December 31, 2020 | 106.19M |
| June 30, 2020 | 105.29M |
| June 30, 2020 | 105.29M |
| December 31, 2019 | 60.57M |
| Date | Value |
|---|---|
| June 30, 2019 | 60.97M |
| June 30, 2019 | 60.97M |
| December 31, 2018 | 43.78M |
| June 30, 2018 | 45.67M |
| June 30, 2018 | 45.67M |
| December 31, 2017 | 45.75M |
| June 30, 2017 | 20.41M |
| June 30, 2017 | 20.41M |
| December 31, 2016 | 9.264M |
| June 30, 2016 | 13.18M |
| June 30, 2016 | 13.18M |
| December 31, 2015 | 6.102M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.96M
Minimum
Dec 2023
106.19M
Maximum
Dec 2020
61.46M
Average
60.57M
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | 7.470M |
| NuCana PLC | 16.46M |
| TC BioPharm (Holdings) PLC | 7.957M |
| Adaptimmune Therapeutics PLC | 243.10M |
| Autolus Therapeutics PLC | 263.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 66.50M |
| Shareholders Equity (Quarterly) | 50.54M |
| Debt to Equity Ratio | 0.0869 |
| Current Ratio | 6.722 |
| Net Debt Paydown Yield | 1.54% |